Drugmakers have to go through rigorous tests to get a lower tariff rate

Pharmaceutical companies seeking a reduced 20% tariff rate will face stringent requirements, including extensive paperwork and oversight from the Department of Commerce. This initiative, part of an executive order signed by President Donald Trump, aims to ensure compliance and accountability within the industry.